Identification of pSTAT5 gene signature in hematologic malignancy.

Authors

null

Dmitriy Sonkin

Novartis Institutes for BioMedical Research, Inc., Cambridge, MA

Dmitriy Sonkin , Catherine Regnier , Xianhui Rong , Christie Fanton , Michael Palmer , Jocelyn Holash , Matthew Squires , L. Andres Sirulnik , Thomas Radimerski , Robert Schlegel , Michael Morrissey , Z, Alexander Cao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Leukemia, Myelodysplasia, and Transplantation

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Myeloproliferative Neoplasms (MPN) and Mast Cell Disorders

Citation

J Clin Oncol 31, 2013 (suppl; abstr 7111)

DOI

10.1200/jco.2013.31.15_suppl.7111

Abstract #

7111

Poster Bd #

43G

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Breakthrough

Preclinical evaluation of JAK2 specific investigational oligonucleotide for the treatment of MDS/PV.

Preclinical evaluation of JAK2 specific investigational oligonucleotide for the treatment of MDS/PV.

First Author: Bartlomiej Przychodzen

Poster

2019 ASCO Annual Meeting

Mechanism of biologic therapy for pre B-cell acute lymphoblastic leukemia with CRLF2 overexpression.

Mechanism of biologic therapy for pre B-cell acute lymphoblastic leukemia with CRLF2 overexpression.

First Author: WayAnne Watson

First Author: Sherri Z. Millis

First Author: Gargi Dan Basu